FDA Approved: APHEXDA — Original Application (Gamida Cell Inc.)

View source ↗

Summary

FDA approved APHEXDA (motixafortide) from Gamida Cell as a new drug to mobilize hematopoietic stem cells in adults with multiple myeloma or non-Hodgkin lymphoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• APHEXDA (motixafortide)

Snippet

ORIG AP for APHEXDA (MOTIXAFORTIDE)